Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index

SAN FRANCISCO and SUZHOU, China, Nov. 21, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other...

from PR Newswire: https://ift.tt/3nDP9hq